GLP-1 originating from the gut has a very short circulating half-life of only 12 min due to its rapid inactivation by the enzyme dipeptidylpeptidase-4 (DPP-4) and subsequent clearance through the kidneys
It is important to note, however, that the data summarized here include only preclinical studies
REDUCE CHRONIC CONDITIONS By targeting both weight loss and blood sugar control, Tirzepatide helps reduce the risk of chronic conditions such as cardiovascular disease, diabetes, and other obesity-related health complications, promoting lasting wellness
# Adherence and Acceptability: A significant finding of the study was the difference in participant retention: * Retention Rates: Inulin had a remarkably low dropout rate of 3.6%, whereas the PSE group had a significantly higher dropout rate of 21%
The results for WR after surgery demonstrated similarly non-significant findings across all demographic variables
We will see more trials soon to show us where these new medications fit in the heart failure treatment algorithm. Majid Basit, MD